colforsin has been researched along with Parkinson Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagda, R; Dagda, RK; Grigoruta, M; Martinez, B; Vazquez-Mayorga, E | 1 |
| Al-Ghamdi, AH; Alanazi, WA; Alharbi, M; Alshammari, A; Alshanwani, AR; Chhabra, S; Kalfin, R; Kalra, S; Kaur, G; Kumar, N; Mehan, S; Narula, AS; Suri, M | 1 |
| Fu, RH; Huang, YC; Lin, CY; Tsai, CW; Wu, CR; Wu, HT | 1 |
| Fan, SH; Han, XR; Hu, B; Li, MQ; Lu, J; Shan, Q; Shen, M; Sun, CH; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, ZF; Zheng, YL; Zhuang, J | 1 |
| Biraud, M; Clairembault, T; Derkinderen, P; Neunlist, M; Paillusson, S | 1 |
| Cho, H; Dezawa, M; Hoshino, M; Ide, C; Ishikawa, H; Itokazu, Y; Kanno, H; Kitada, M; Matsumoto, N; Mimura, T; Sawada, H; Suzuki, Y; Tajima, N; Yamada, H | 1 |
| He, Q; Li, L; Liu, X; Lu, Y; Wang, K; Wang, X; Wang, Y; Zhang, H | 1 |
| Chen, SD; Fan, GH; Qi, C; Wang, G; Zhou, HY | 1 |
| Feenstra, RW; Glennon, JC; Hesselink, MB; Long, SK; McCreary, AC; Reinders, JH; Ronken, E; Van Der Neut, M; Van Scharrenburg, G | 1 |
| Iacovitti, L; Jin, H; Stull, ND | 1 |
| Fei, J; Guo, L; Liu, Z; Zhang, J | 1 |
| Bradford, HF; Jauniaux, E; Riaz, SS; Stern, GM | 1 |
12 other study(ies) available for colforsin and Parkinson Disease
| Article | Year |
|---|---|
Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats.
Topics: Animals; Colforsin; Disease Models, Animal; Dopaminergic Neurons; Humans; Levodopa; Mesencephalon; Neurodegenerative Diseases; Parkinson Disease; Protein Kinases; Rats; Substantia Nigra | 2022 |
Effect of Natural Adenylcyclase/cAMP/CREB Signalling Activator Forskolin against Intra-Striatal 6-OHDA-Lesioned Parkinson's Rats: Preventing Mitochondrial, Motor and Histopathological Defects.
Topics: Adenylyl Cyclases; Animals; Colforsin; Mitochondria; Oxidopamine; Parkinson Disease; Rats | 2022 |
Carnosic acid attenuated cytochrome c release through the mitochondrial structural protein Mic60 by PINK1 in SH-SY5Y cells.
Topics: Apoptosis; Cell Line, Tumor; Colforsin; Cytochromes c; Humans; Mitochondria; Mitochondrial Proteins; Neuroblastoma; Oxidopamine; Parkinson Disease; Protein Kinases; RNA, Small Interfering | 2023 |
Inhibition of microRNA-200a Upregulates the Expression of Striatal Dopamine Receptor D2 to Repress Apoptosis of Striatum via the cAMP/PKA Signaling Pathway in Rats with Parkinson's Disease.
Topics: Animals; Apoptosis; Colforsin; Corpus Striatum; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Down-Regulation; Genetic Therapy; Male; MicroRNAs; Parkinson Disease; Rats, Sprague-Dawley; Receptors, Dopamine D2; Signal Transduction; Up-Regulation | 2018 |
Activity-dependent secretion of alpha-synuclein by enteric neurons.
Topics: alpha-Synuclein; Animals; Blotting, Western; Brefeldin A; Colforsin; Enteric Nervous System; Exocytosis; Intestine, Small; Neurons; Parkinson Disease; Primary Cell Culture; Protein Synthesis Inhibitors; Rats | 2013 |
Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.
Topics: Animals; Biomarkers; Bone Marrow Cells; Cell Transplantation; Cells, Cultured; Ciliary Neurotrophic Factor; Colforsin; Fibroblast Growth Factor 2; Glial Cell Line-Derived Neurotrophic Factor; Humans; Membrane Proteins; Nerve Growth Factors; Neurons; Parkinson Disease; Phenotype; Protein Structure, Tertiary; Rats; Rats, Wistar; Receptors, Notch; Stromal Cells; Transcription Factors; Transfection; Transplantation, Autologous; Tyrosine 3-Monooxygenase; Visual Cortex | 2004 |
Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Cell Differentiation; Cell Division; Cells, Cultured; Chromatography, High Pressure Liquid; Colforsin; Corpus Striatum; Disease Models, Animal; Dopamine; Embryo, Mammalian; Female; Fibroblast Growth Factor 8; Fibroblast Growth Factors; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Humans; Intermediate Filament Proteins; Ki-67 Antigen; Mesencephalon; Nerve Growth Factors; Nerve Tissue Proteins; Nestin; Neurofilament Proteins; Neurons; Parkinson Disease; Rats; Recovery of Function; Stem Cell Transplantation; Stem Cells; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone.
Topics: Animals; Bucladesine; Caspase 3; Caspases; Cell Differentiation; Cell Survival; Colforsin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Intracellular Membranes; Isoquinolines; MAP Kinase Signaling System; Membrane Potentials; Mitochondria; Nerve Growth Factors; Neurons; Neuropeptides; Neurosecretory Systems; Neurotransmitter Agents; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; PC12 Cells; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Kinase Inhibitors; Rats; Rotenone; Signal Transduction; Sulfonamides | 2005 |
In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Topics: Animals; Benzoxazoles; Binding, Competitive; Brain; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lisuride; Male; Molecular Structure; Parkinson Disease; Piperazines; Quinpirole; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Fusion Proteins; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists | 2006 |
Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line.
Topics: 1-Methyl-3-isobutylxanthine; 3,4-Dihydroxyphenylacetic Acid; Cell Differentiation; Colforsin; Culture Techniques; Dopamine; Fibroblast Growth Factor 1; Humans; Immunohistochemistry; Models, Biological; Neoplastic Stem Cells; Neurons; Parkinson Disease; Phosphodiesterase Inhibitors; Tissue Plasminogen Activator; Tyrosine 3-Monooxygenase | 2001 |
A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter.
Topics: Animals; Apoptosis; Cell Membrane; Cell Survival; CHO Cells; Colforsin; Cricetinae; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Microscopy, Electron; Nerve Tissue Proteins; Neurons; Neurotoxins; Parkinson Disease; Substantia Nigra; Tumor Cells, Cultured | 2001 |
The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro.
Topics: 3,4-Dihydroxyphenylacetic Acid; Brain Tissue Transplantation; Brain-Derived Neurotrophic Factor; Cell Differentiation; Colforsin; Dopamine; Fetal Tissue Transplantation; Fetus; Humans; In Vitro Techniques; Mesencephalon; Neurons; Parkinson Disease; Phenotype; Stem Cells; Tyrosine 3-Monooxygenase | 2002 |